These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5767788)

  • 1. Membrane alterations in hemolysis: Internalization of plasmalemma induced by primaquine.
    Ginn FL; Hochstein P; Trump BF
    Science; 1969 May; 164(3881):843-5. PubMed ID: 5767788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intracellular and membrane effects of oxidant agents on normal red cells.
    Miller A; Smith HC
    Br J Haematol; 1970 Sep; 19(3):417-28. PubMed ID: 5469591
    [No Abstract]   [Full Text] [Related]  

  • 3. Primaquine-induced hemolysis of normal erythrocytes in vitro: the requirement for energy.
    Berry DH; Hochstein P
    Biochem Med; 1970 Nov; 4(3):317-26. PubMed ID: 4257451
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced erythrocyte membrane internalization.
    Ben-Bassat I; Bensch KG; Schrier SL
    J Clin Invest; 1972 Jul; 51(7):1833-44. PubMed ID: 4555785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of hemolysis in vitro for the purpose of detecting primaquine sensitivity].
    Allakhverdiev AM; Grinberg LN
    Lab Delo; 1981; (12):724-6. PubMed ID: 6172643
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of glucose and exogenous glutathione on the red cell membrane effect of the antimalarial drugs 1,4-naphthoquinone and beta-naphthol.
    Miller A; Smith HC
    Br J Haematol; 1971 Jun; 20(6):599-609. PubMed ID: 5089950
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of phospholipid metabolism in human red cells by primaquine. A possible mechanism in drug-induced hemolysis.
    Wittels B
    Biochim Biophys Acta; 1970 Jun; 210(1):74-85. PubMed ID: 5456047
    [No Abstract]   [Full Text] [Related]  

  • 8. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
    Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ascorbic acid on hemolysis induced in vitro by primaquine].
    Grinberg LN; Vong NK
    Gematol Transfuziol; 1983 Dec; 28(12):50-2. PubMed ID: 6662338
    [No Abstract]   [Full Text] [Related]  

  • 10. The hemolytic effect of primaquine V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.
    Dern RJ; Beutler E; Alving AS
    J Lab Clin Med; 1981 Jun; 97(6):750-9. PubMed ID: 7229509
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methemoglobin formation in the erythrocytes of mice as affected by primaquine metabolites and the protective action of antioxidants].
    Sokhanenkova TL; Soprunov FF; Sergacheva IuIu
    Med Parazitol (Mosk); 1984; (4):22-4. PubMed ID: 6482834
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemolysis induced by Prymnesium parvum toxin. Effect of primaquine treatment.
    Martin DF; Padilla GM; Brown PA
    Biochim Biophys Acta; 1971 Oct; 249(1):69-80. PubMed ID: 5141135
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of in vitro primaquine hemolysis: substrate requirement for erythrocyte membrane damage.
    George JN; O'Brien RL; Pollack S; Crosby WH
    J Clin Invest; 1966 Aug; 45(8):1280-9. PubMed ID: 5926074
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemolytic effect of primaquine and the protective properties of sodium formate in vitro].
    Grinberg LN; Allakhverdiev AM
    Med Parazitol (Mosk); 1981; 50(2):54-7. PubMed ID: 7231374
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations in normal and G-6-PD deficient human erythrocytes of various ages after exposure to metabolites of hemolytic drugs.
    Fraser IM; Tilton BE; Vesell ES
    Pharmacology; 1971; 5(3):173-87. PubMed ID: 5119006
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
    Ganesan S; Chaurasiya ND; Sahu R; Walker LA; Tekwani BL
    Toxicology; 2012 Mar; 294(1):54-60. PubMed ID: 22330256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophoretic study of normal erythrocyte membrane proteins after in vitro action of antimalarial agents].
    Kotsifopoulos PN
    Pathol Biol (Paris); 1975 Apr; 23(4):313-4. PubMed ID: 1097994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study.
    Alanazi FK; Harisa Gel-D; Maqboul A; Abdel-Hamid M; Neau SH; Alsarra IA
    Arch Pharm Res; 2011 Apr; 34(4):563-71. PubMed ID: 21544721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirements of drug-induced endocytosis by intact human erythrocytes.
    Schrier SL; Junga I; Krueger J; Johnson M
    Blood Cells; 1978; 4(1-2):339-59. PubMed ID: 218658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro shape changes of human erythrocyte membranes.
    Fujii T; Sato T; Nakanishi K
    Physiol Chem Phys; 1973; 5(5):423-30. PubMed ID: 4775588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.